Crystal Structure of Von Willebrand Factor (VWF) A1 Domain in Complex with Aptamer ARC1172, An Inhibitor of VWF-Platelet Binding

被引：0
|
作者：
Huang, Ren-Huai [1 ]
Fremont, David [2 ]
Tuley, Elodee A. [1 ]
Diener, John L. [3 ]
Schaub, Robert G. [4 ]
Sadler, J. Evan [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA
[3] Novartis Inst BioMed Res Inc, Cambridge, MA USA
[4] Archemix Corp, Cambridge, MA USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [21] Effect of AJvW-2, anti-human von Willebrand factor (vWF) A1 domain MoAb, on vWF-dependent platelet aggregation following coronary stent implantation
    Eto, K
    Isshiki, T
    Ochiai, M
    Takeshita, S
    Mitani, H
    Tokuda, T
    Sato, T
    Yamamoto, H
    Yoshimoto, R
    CIRCULATION, 1998, 98 (17) : 573 - 573
  • [22] THE EFFECT OF ABO TYPE ON THE SYNTHESIS, RELEASE, AND PLATELET BINDING OF VON-WILLEBRAND-FACTOR (VWF)
    SCOTT, JP
    GILL, JC
    ROCK, A
    LEVINE, S
    VOKAC, EA
    MONTGOMERY, RR
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 946 - 946
  • [23] The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin
    Katarina D. Kovacevic
    Nina Buchtele
    Christian Schoergenhofer
    Ulla Derhaschnig
    Georg Gelbenegger
    Christine Brostjan
    Shuhao Zhu
    James C. Gilbert
    Bernd Jilma
    Scientific Reports, 10
  • [24] The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin
    Kovacevic, Katarina D.
    Buchtele, Nina
    Schoergenhofer, Christian
    Derhaschnig, Ulla
    Gelbenegger, Georg
    Brostjan, Christine
    Zhu, Shuhao
    Gilbert, James C.
    Jilma, Bernd
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [25] The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF
    Rosenberg, JB
    Haberichter, SL
    Jozwiak, MA
    Vokac, EA
    Kroner, PA
    Fahs, SA
    Kawai, YK
    Montgomery, RR
    BLOOD, 2002, 100 (05) : 1699 - 1706
  • [26] Binding of the von Willebrand Factor A1 domain to histone
    Ward, CM
    Tetaz, TJ
    Andrews, RK
    Berndt, MC
    THROMBOSIS RESEARCH, 1997, 86 (06) : 469 - 477
  • [27] A mutation in the D4 domain of von Willebrand factor (VWF) results in a variant of type 1 von Willebrand disease with accelerated in vivo VWF clearance.
    Gavazova, S
    Gill, JC
    Scott, JP
    Hillery, CA
    Friedman, KD
    Wetzel, N
    Jozwiak, M
    Haberichter, SL
    Christopherson, P
    Montgomery, RR
    BLOOD, 2002, 100 (11) : 128A - 128A
  • [28] Increased von Willebrand factor (vWf)-platelet binding and decreased vWf-metalloproteinase in ticlopidine-induced thrombotic thrombocytopenic purpura (TTP).
    Rice, L
    Tsai, HM
    Chow, TW
    Moake, JL
    BLOOD, 1998, 92 (10) : 706A - 707A
  • [29] Von Willebrand factor (VWF) binding to collagen and mediation of platelet adhesion under physiological flow conditions
    Fuchs, B.
    Budde, U.
    Fisseau, C.
    Kannicht, C.
    HAEMOPHILIA, 2008, 14 : 113 - 113
  • [30] Quantitation of binding of Ricinus communis Agglutinin I to von Willebrand factor (VWF):: Investigation of relationship with plasma clearance of VWF in type 1 von Willebrand disease.
    Millar, CM
    Riddell, AF
    Brown, SA
    BLOOD, 2005, 106 (11) : 215A - 216A
12345